Top Markets
#1 Siacoin Siacoin +52.09%
#2 Official Trump Official Trump +32.45%
#3 Nockchain Nockchain +22.11%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.90%
#5 Melania Meme Melania Meme +19.03%
#6 EXOD EXOD +18.93%
#7 MowCat MowCat +18.80%
#8 Mubarak Mubarak +17.99%
#9 Pump.fun Pump.fun +15.74%
#10 Unit Pump Unit Pump +14.10%
Coin of the day
Siacoin Siacoin
설정
언어
한국어
통화
USD
테마
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
주식 순위 #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
주가
$19.30
마지막 동기화: 2023-12-26
시가총액
$72.77M
변동 (1일)
6.22%
변동 (1년)
0.00%
국가
US
거래 Aeglea BioTherapeutics, Inc. (AGLE)

카테고리

Healthcare
Aeglea BioTherapeutics, Inc. (AGLE)의 주식 분할 이력
Aeglea BioTherapeutics, Inc. 주식 (심볼: AGLE)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 22, 2026에 발생했습니다.
Aug 22, 2026 이전에 매수한 AGLE 주식 1주는 현재 0주의 AGLE 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH